Dublin, April 06, 2020 -- The "U.S. Patient Monitoring Devices Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering..
Man Group plc grew its stake in shares of BioTelemetry Inc (NASDAQ:BEAT) by 24.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commiss
BioTelemetry, Inc. (NASDAQ:BEAT), which is in the healthcare business, and is based in United States, led the NASDAQGS...
Patient monitoring devices provide assistance in continuous measurement of a patient's health parameter such as heart rate, respiratory rate, blood pressure, blood oxygen saturation and many other par
Brinker Capital Inc. increased its holdings in shares of BioTelemetry Inc (NASDAQ:BEAT) by 18.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commi
Advisor Group Inc. reduced its position in BioTelemetry Inc (NASDAQ:BEAT) by 32.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The instituti
BioTelemetry Inc (NASDAQ:BEAT) was the target of a large increase in short interest during the month of March. As of March 13th, there was short interest totalling 2,686,100 shares, an increase of 7.0
Negative global GDP growth rate estimate is concerning, but what is even more dreadful is Nomura’s bad scenario where coronavirus “beats us.”
BioTelemetry Inc (NASDAQ:BEAT) – Dougherty & Co decreased their Q1 2020 earnings estimates for shares of BioTelemetry in a research report issued to clients and investors on Monday, March 30th. Doug
BioTelemetry (NASDAQ:BEAT) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Tuesday, BidAskClub reports. A number of
Amalgamated Bank grew its position in BioTelemetry Inc (NASDAQ:BEAT) by 7.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission
To the annoyance of some shareholders, BioTelemetry (NASDAQ:BEAT) shares are down a considerable 32% in the last...
BioTelemetry, Inc. (BEAT), a leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced the activation
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE